Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Net Margin (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Net Margin for 6 consecutive years, with 721.97% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 114972.0% to 721.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1329.37% through Dec 2025, up 33779.0% year-over-year, with the annual reading at 1327.4% for FY2025, 16454.0% up from the prior year.
  • Net Margin for Q4 2025 was 721.97% at Caribou Biosciences, up from 1337.58% in the prior quarter.
  • The five-year high for Net Margin was 61.84% in Q3 2023, with the low at 1893.87% in Q1 2024.
  • Average Net Margin over 5 years is 1079.86%, with a median of 881.92% recorded in 2023.
  • The sharpest move saw Net Margin crashed -182739bps in 2024, then soared 114972bps in 2025.
  • Over 5 years, Net Margin stood at 722.12% in 2021, then fell by -15bps to 828.22% in 2022, then fell by -27bps to 1052.33% in 2023, then crashed by -78bps to 1871.69% in 2024, then skyrocketed by 61bps to 721.97% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 721.97%, 1337.58%, and 1783.95% for Q4 2025, Q3 2025, and Q2 2025 respectively.